About one-third of US adults without diabetes who are eligible for weight loss treatment with GLP-1 receptor agonists and GLP-1/GIP receptor agonists meet exclusion criteria for clinical trials.

Laparoscopic procedures are a frequently chosen option for removing colorectal growths. During these surgeries, the use of ...

Amyloidosis is a rare, multisystem disease that leads to deposition of misfolded proteins in various organs. This case report ...

A subset of patients with myeloproliferative neoplasms (MPNs) -- clonal disorders of hematopoietic stem cells that include ...

A decade after the discovery of CALR, the results are the first for a possible therapy for CALR-mutated MPNs to reach the ...

Skull-base tumors, a subset of neoplasms, present a formidable challenge in the field of oncology due to their complex anatomical location at the interface of the brain and skull-base. These tumors ...

Researchers sought to determine trends in participation and detection of CRC in multiround FIT-based CRC screening.

A new thesis from Karolinska Institutet shows the effectiveness of flexible parametric survival models in modeling multiple ...

After going through the gapfill process and releasing final pricing for six codes related to genomic sequencing procedures, ...

In the US, liraglutide, semaglutide, and tirzepatide are currently under investigation for their ability to stimulate weight ...

PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and ...

Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicular Lymphoma, at the 2024 ...